The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 6, 2005, Pages 708-716

  Peremans, K ^a   Audenaert, K ^b   Hoybergs, Y ^a   Otte, A ^c   Goethals, I ^c   Gielen, I ^a   Blankaert, P ^a   Vervaet, M ^b   Van Heeringen, C ^b   Dierckx, R ^c  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

5 HT2A receptor; 123I 5 I R91150; Citalopram hydrobromide; Dogs; Impulsive aggression; SPECT

Indexed keywords

5 I R91150; 5 I R91150 I 123; CITALOPRAM; CYSTEINE ETHYL ESTER TC 99M; RADIOPHARMACEUTICAL AGENT; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

AGGRESSION; ANIMAL MODEL; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; BINDING AFFINITY; BRAIN CORTEX; BRAIN PERFUSION; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; IMPULSIVENESS; MALE; MEASUREMENT; NONHUMAN; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CITALOPRAM; DOGS; IMPULSIVE BEHAVIOR; PIPERIDINES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN UPTAKE INHIBITORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 18144396848     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1772-5     Document Type: Article

References (53)

1. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994;51:20-7.
2. Cremniter D, Jamain S, Kollenbach K, Alvarez JC, Lecrubier Y, Gilton A, et al. CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. Biol Psychiatry 1999;45:1572-9.
3. Higley JD, Mehlman PT, Higley SB, Fernald B, Vickers J, Lindell SG, et al. Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Arch Gen Psychiatry 1996;53:537-43.
4. Fairbanks L, Melega W, Jorgensen M, Kaplan J, McGuire M. Social impulsivity inversely associated with CSF 5-HIAA and fluoxetine exposure in vervet monkeys. Neuropsychopharmacology 2001;24:370-8.
5. Reisner IR, Mann JJ, Stanley M, Huang Y, Houpt KA. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and non-aggressive dogs. Brain Res 1996;714:57-64.
6. Soloff P, Kelly T, Strotmeyer S, Malone K, Mann J. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res 2003;119:11-24.
7. Rinne T, Westenberg H, Den Boer J, van den Brink W. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biol Psychiatry 2000;47:548-56.
8. Tiefenbacher S, Davenport M, Novack M, Pouliot A, Meyer J. Fenfluramine challenge self-injurious behaviour, and aggression in rhesus monkeys. Physiol Behav 2003;80:327-31.
9. Popova NK, Voitenko NN, Kulikov AV, Avgustinovich DF. Evidence for the involvement of central serotonin in mechanism of domestication of silver foxes. Pharmacol Biochem Behav 1991;40:751-6.
10. Popova NK, Kulikov AV, Nikulina EM, Kozlachkova EY, Maslova GB. Serotonin metabolism and serotonergic receptors in Norway rats selected for low aggressiveness towards man. Aggressive Behav 1991;17:207-13.
11. Coccaro E, Kavoussi R. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997;54:1081-8.
12. Cherek DR, Lane SD, Pietras CJ, Steinberg JL. Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder. Psychopharmacology (Berlin) 2002;159:266-74.
13. Reist C, Nakamura K, Sagart E, Sokolski KN, Fujimoto KA. Impulsive aggressive behavior: open-label treatment with citalopram. J Clin Psychiatry 2003;64:81-5.
14. Verkes R, Van der Mast R, Hengeveld M, Tuyl J, Zwinderman A, Van Kempen G. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but no major depression. Am J Psychiatry 1998;155:543-7.
15. Perreault HA, Semsar K, Godwin J. Fluoxetine treatment decreases territorial aggression in a coral reef fish. Physiol Behav 2003;79:719-24.
16. Sperry TS, Thompson CK, Wingfield JC. Effects of acute treatment with 8-OH-DPAT and fluoxetine on aggressive behaviour in male song sparrows (Melospiza melodia morphna). J Neuroendocrinol 2003;15:150-60.
17. Medeiros JM, Silva CM, Sougey EB, Costa JA, Castro CM, Castro RM. Action of selective serotonin reuptake inhibitor on aggressive behavior in adult rat submitted to the neonatal malnutrition. Arq Neuropsiquiatr 2001;59:499-503.
18. Neuger J, Wistedt B, Aberg-Wistedt A, Stain-Malmgren R. Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients. J Clin Psychopharmacol 2002;22:400-5.
19. Berton O, Durand M, Aguerre S, Mormede P, Chaouloff F. Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain. Neuroscience 1999;92:327-41.
20. Benmansour S, Cecchi M, Morilak D, Gerhardt G, Javors M, Gould G, et al. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 1999;19:10494-501.
21. Chen F, Lawrence A. The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-hooded rats: a quantitative autoradiography study. Brain Res 2003;976:22-9.
22. Lepoul E, Laaris N, Doucet E, Laporte A, Hamon M, Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 1995;352:141-8.
23. Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, van Heeringen C, et al. Decreased frontal serotonin 5-HT2a receptor binding index in deliberate self harm patients. Eur J Nucl Med 2001;28:175-82.
24. Parsey R, Oquendo M, Simpson N, Ogden R, Van Heertum R, Arango V, et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A binding potential measured by PET using [C-11] WAY-100635. Brain Res 2002;954:173-182.
25. Tiihonen J, Kuikka J, Bergstrom K, Karhu J, Viinamaki H, Lehtonen J, et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. Eur J Nucl Med 1997;24:1253-60.
26. 123I-5-I-5- R91150. Eur J Nucl Med Mol Imaging 2003;30:1538-46.
27. Mertens J, Terriere D, Sipido V, Gommeren W, Janssen PMF, Leysen JE. Radiosynthesis of a new radioiodinated ligand for serotonin-5HT2-receptors, a promising tracer for gamma-emission tomography. J Label Compd Radiopharm 1995;34:795-801.
28. 123I-5-I-R91150 in the normal dog. Nucl Med Commun 2002;23:1019-27.
29. Peremans K, De Bondt P, Audenaert K, Van Laere K, Gielen I, Koole M, et al. Regional brain perfusion in 10 healthy dogs measured using technetium-99m ethyl cysteinate dimer SPECT: a normal database. Vet Radiol Ultrasound 2001;42:562-8.
30. Peremans K, Audenaert K, Coopman F, Jacobs F, Blanckaert P, Verschooten F, et al. Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 1393-404.
31. Pazos A, Cortes R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 1985;346:231-49.
32. Pazos A, Probst A, Palacios J. Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987;21:123-39.
33. Travis M, Busatto G, Pilowsky L, Mulligan R, Acton P, Gacinovic S, et al. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone and clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150. Br J Psychiatry 1998;173:236-41.
34. Kerwin R, Pilowsky L. Traditional receptor theory and its application to neuroreceptor measurements in functional imaging. Eur J Nucl Med 1995;22:699-710.
35. Van der Linden G., van Heerden B, Warwick J, Wessels C, van Kradenburg J, Zungu-Dirwayi N, et al. Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:419-38.
36. Kennedy SH, Evans KR, Kruger S, Mayberg HS, Meyer JH, McCann S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001;158:899-905.
37. Bonne O, Krausz Y, Aharon Y, Gelfin Y, Chisin R, Lerer B. Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers. Psychopharmacology (Berlin) 1999;143:24-8.
38. Massou JM, Trichard C, Attar-Levy D, Feline A, Corruble E, Beaufils B, et al. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology (Berlin) 1997;133:99-101.
39. 18F]setoperone PET imaging study. Am J Psychiatry 2001;158:78-85.
40. Zanardi R, Artigas F, Moresco R, Colombo C, Messa C, Gobbo C, et al. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol 2001;21:53-8.
41. 2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berlin) 2003;167:72-8.
42. Rilke O, Will K, Jahkel M, Oehler J. Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:1125-44.
43. Rutter JJ, Gundlah C, Auerbach SB. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 1994;171:183-6.
44. 18F]-setoperone PET. Psychopharmacology (Berlin) 1999;144:279-81.
45. Reisner IR. Assessment, management, and prognosis of canine dominance-related aggression. Vet Clin North Am Small Anim Pract 1997;27:479-95.
46. Dodman NH, Donnelly R, Shuster L, Mertens P, Rand W, Miczek K. Use of fluoxetine to treat dominance aggression in dogs. J Am Vet Med Assoc 1996;209:1585-7.
47. Raleigh MJ, McGuire MT, Brammer GL, Pollack DB, Yuwiler A. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Res 1991;559:181-90.
48. Fuller RW. The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology 1996;14:77-81.
49. Wolff MC, Leander JD. Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon. Neuropsychopharmacology 2002;27:421-9.
50. Takao K, Nagatani T, Kitamura Y, Kawasaki K, Hayakawa H, Yamawaki S. Chronic forced swim stress of rats increases frontal cortical 5-HT2 receptors and the wet-dog shakes they mediate, but not frontal cortical beta-adrenoceptors. Eur J Pharmacol 1995;294:721-6.
51. Koskinen T, Ruotsalainen S, Puumala T, Lappalainen R, Koivisto E, Mannisto PT, et al. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 2000;39:471-81.
52. Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology (Berlin) 2003;167:304-14.
53. Ito H, Nyberg S, Halldin C, Lundkvist C, Farde L. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. J Nucl Med 1998;39:208-14.